Leon J de Windt
Founder at Mirabilis Therapeutics BV
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jan Wit | M | - |
Mirabilis Therapeutics BV
 Mirabilis Therapeutics BV Pharmaceuticals: MajorHealth Technology Mirabilis Therapeutics BV develops microRNA medicines. The Dutch company was founded in 2015 by Leon J de Windt, Jan Wit, and Paula A. Da Costa Martins. Jan Wit has been the CEO since 2015. | 9 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sjef de Kimpe | M | - |
University of Utrecht
| 10 years |
| Gerardus Cornelis M. W. Embrechts | M | 54 |
Maastricht University
| 7 years |
| Ingrid M. A. de Graaf-de Swart | M | 55 |
University of Utrecht
| 6 years |
| Sebastian Gröblinghoff | M | 45 |
Maastricht University
| 5 years |
| Geofrey de Visscher | M | - |
Maastricht University
| 3 years |
| Valentina Pippolo | F | - |
Maastricht University
| 4 years |
| Jan Bongaerts | M | 58 |
Maastricht University
| 2 years |
| Bas Xue | M | - |
University of Utrecht
| 4 years |
| Angelien G. Z. Kemna | M | 66 |
Maastricht University
| 6 years |
| Yvo Timmermans | M | - |
Maastricht University
| 6 years |
| Coenraad Johannes Weddepohl | M | - |
Maastricht University
| 4 years |
| Mirjam 't Lam | F | - |
Maastricht University
| 5 years |
| Hubertus J. M. Vrijhoef | M | - |
Maastricht University
| 3 years |
| Marc Rasmussen | M | - |
Maastricht University
| 7 years |
| Susan Gustafsson | F | 51 |
Maastricht University
| 1 years |
| Robin Schaede | M | 49 |
Maastricht University
| 5 years |
| Carolien Reijnen | F | - |
Maastricht University
| 5 years |
| Zhong Xi Cai | M | 59 |
Maastricht University
| 2 years |
| Xing Gang Qi | M | 51 |
Maastricht University
| 1 years |
| Steven ten Have | M | 56 |
University of Utrecht
| 3 years |
| Robbert Kessels | M | 49 |
Maastricht University
| 1 years |
| Fan Jianxiong | M | - |
Maastricht University
| 2 years |
| Caroline Princen | F | 57 |
University of Utrecht
| 4 years |
| Leon J. Schurgers | M | - |
Maastricht University
| 3 years |
| Ad W. van Gorp | M | - |
University of Utrecht
| 1 years |
| Pieter Doevendans | M | - |
Maastricht University
| 3 years |
| Nikolai R. D. Pronk | M | 50 |
Maastricht University
| 5 years |
| André van Puijenbroek | M | - |
University of Utrecht
| 1 years |
| Min Jie Xu | M | 65 |
Maastricht University
| 2 years |
| Ruud Wilders | M | - |
Maastricht University
| 10 years |
| Renée LeMaire | F | - |
Maastricht University
| 3 years |
| Marc van Dijk | M | 61 |
University of Utrecht
| 3 years |
| Peter Schrijnemaekers | M | 57 |
Maastricht University
| 7 years |
| Peter Wijngaard | M | 61 |
University of Utrecht
| 2 years |
| Ingo Jeroen Uytdehaage | M | 51 |
Maastricht University
| 2 years |
| Paula A. Da Costa Martins | F | - |
Mirabilis Therapeutics BV
Mirabilis Therapeutics BV Pharmaceuticals: MajorHealth Technology Mirabilis Therapeutics BV develops microRNA medicines. The Dutch company was founded in 2015 by Leon J de Windt, Jan Wit, and Paula A. Da Costa Martins. Jan Wit has been the CEO since 2015. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Netherlands | 37 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Leon J de Windt
- Personal Network
